共 50 条
Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells
被引:0
|作者:
Ceshi Chen
Xiaodong Sun
Qimei Ran
Keith D Wilkinson
T J Murphy
Jonathan W Simons
Jin-Tang Dong
机构:
[1] Winship Cancer Institute,Department of Oncology and Hematology
[2] Emory University School of Medicine,Department of Biochemistry
[3] Emory University School of Medicine,Department of Pharmacology
[4] Emory University School of Medicine,Department of Urology and Program in Genetics and Molecular Biology
[5] Emory University School of Medicine,undefined
来源:
关键词:
KLF5;
degradation;
ubiquitin;
proteasome;
cancer;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1α, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination–proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
引用
收藏
页码:3319 / 3327
页数:8
相关论文